About the role
About Us
Deep Genomics is at the forefront of using artificial intelligence to transform drug discovery. Our proprietary AI platform decodes the complexity of RNA biology to identify novel drug targets, mechanisms, and therapeutics inaccessible through traditional methods. With expertise spanning machine learning, bioinformatics, data science, engineering, and drug development, our multidisciplinary team in Toronto and Cambridge, MA is revolutionizing how new medicines are created.
Opportunity
Join us in building the future of AI-driven drug discovery as a Senior MLOps Engineer. You will own and evolve the infrastructure that powers our ML pipelines – from cloud environments and CI/CD systems to workflow orchestration and model deployment. You will work closely with ML scientists, bioinformaticians, and software engineers to keep our platform reliable, reproducible, and scalable.
Ideal Candidate
You are someone who enjoys keeping the infrastructure running smoothly so that scientists can focus on their research. You are comfortable working across cloud platforms, CI/CD systems, containers, and GPUs – and you take pride in making these systems reliable and easy for others to use. You have 4+ years of experience in production infrastructure or MLOps, you write solid Python, and you are curious about the ML and scientific workflows your work supports. Above all, you are a collaborative, kind team member who communicates clearly, adapts to evolving needs, and is happy to help colleagues grow their own infrastructure skills along the way. If this sounds like you, we would love to hear from you.
Skills & Tags
Aplyr's read
Deep Genomics leverages AI to revolutionize genetic medicine, attracting professionals passionate about cutting-edge biotechnology and data-driven healthcare solutions.
What's promising
- •Pioneering use of AI in drug discovery accelerates genetic medicine development.
- •Strong focus on innovative solutions for complex genetic disorders.
- •Recent funding rounds indicate robust financial backing for growth.
What to watch
- •High dependency on AI models requires significant computational resources.
- •Regulatory hurdles in genetic medicine could delay product approvals.
- •Intense competition in biotech may impact market share and talent acquisition.
Why Deep Genomics
- •Combines AI with genomics for precise identification of therapeutic targets.
- •Developed proprietary platform for predicting RNA-based drug interactions.
- •Focus on rare genetic disorders sets it apart in the biotech landscape.
Aplyr’s read is generated by AI from public sources. Was it useful?
About Deep Genomics
Deep Genomics is a biotechnology company that utilizes artificial intelligence to discover and develop genetic medicines.